Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
The Journal of Antimicrobial Chemotherapy
|
February 4, 2020
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
Gwendolyn M Pais, Jiajun Liu, Sean N Avedissian, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
February 21, 2026
High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial
Claudia Crimi, Salvatore Sardo, Alberto Noto, et al.
Journal of Intensive Care Medicine
|
May 8, 2023
Effects of Etomidate on Postintubation Hypotension, Inflammatory Markers, and Mortality in Critically Ill Patients with COVID-19: An International, Multicenter, Retrospective Study
Konstantinos Leou, Dianelys Mendez, George Horani, et al.
Critical Care (London, England)
|
July 30, 2021
Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium
Athanasios Chalkias, Nicolas Mongardon, Vladimir Boboshko, et al.
Thorax
|
May 17, 2022
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Claudia Crimi, Alberto Noto, Fabiana Madotto, et al.
JAMA
|
March 23, 2021
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries
Vincenzo Russotto, Sheila Nainan Myatra, John G Laffey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 18, 2024
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
Christina G Hutten, Kishan Padalia, Alexi Vasbinder, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of the American Society of Nephrology : JASN
|
September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI
Tariq U Azam, Husam R Shadid, Pennelope Blakely, et al.
Diabetes Care
|
January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
The Journal of Antimicrobial Chemotherapy
|
February 4, 2020
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
Gwendolyn M Pais, Jiajun Liu, Sean N Avedissian, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
February 21, 2026
High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial
Claudia Crimi, Salvatore Sardo, Alberto Noto, et al.
Journal of Intensive Care Medicine
|
May 8, 2023
Effects of Etomidate on Postintubation Hypotension, Inflammatory Markers, and Mortality in Critically Ill Patients with COVID-19: An International, Multicenter, Retrospective Study
Konstantinos Leou, Dianelys Mendez, George Horani, et al.
Critical Care (London, England)
|
July 30, 2021
Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium
Athanasios Chalkias, Nicolas Mongardon, Vladimir Boboshko, et al.
Thorax
|
May 17, 2022
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Claudia Crimi, Alberto Noto, Fabiana Madotto, et al.
JAMA
|
March 23, 2021
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries
Vincenzo Russotto, Sheila Nainan Myatra, John G Laffey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 18, 2024
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
Christina G Hutten, Kishan Padalia, Alexi Vasbinder, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of the American Society of Nephrology : JASN
|
September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI
Tariq U Azam, Husam R Shadid, Pennelope Blakely, et al.
Diabetes Care
|
January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.
Page
of 14